Manifesto for a European Anxiety Disorders Research NetworkBaldwin, D. S., Allgulander, C., Altamura, A. C., Angst, J., Bandelow, B., den Boer, J., Boyer, P., Davies, S., dell'Osso, B., Eriksson, E., Fineberg, N., Fredrikson, M., Herran, A., Maron, E., Metspalu, A., Nutt, D., van der Wee, N., Luis Vazquez-Barquero, J. & Zohar, J., Jun-2010, In : European Neuropsychopharmacology. 20, 6, p. 426-432 7 p.
Research output: Contribution to journal › Article › Academic › peer-review
Despite the size, burden and costs of anxiety disorders, many patients remain unrecognised, and the effectiveness of evidence-based interventions in routine clinical practice can be disappointing. The European College of Neuropsychopharmacology (ECNP) has established the ECNP Network Initiative (ECNP-NI) to help meet the goal of extending current understanding of the causes of central nervous system disorders, thereby contributing to improvements in clinical outcomes and reducing the associated societal burden. The Anxiety Disorders Research Network (ADRN) has been adopted within the ECNP-NI: this consensus statement summarises its overall aims and objectives. (C) 2010 Elsevier B.V. and ECNP. All rights reserved.
|Number of pages||7|
|Publication status||Published - Jun-2010|
- Anxiety disorders, Research network, Treatment, Outcomes, OBSESSIVE-COMPULSIVE DISORDER, GENERALIZED ANXIETY, PANIC DISORDER, PHARMACOLOGICAL-TREATMENT, SOCIAL PHOBIA, PSYCHIATRIC-DISORDERS, MENTAL-DISORDERS, PRIMARY-CARE, DEPRESSION, AUGMENTATION